Total Funding
2
9
Total FundingPost-IPO Debt raised
Growth Score 2 in past quarter
-2 pts
Heat Score 9 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
424669
Cardiovascular Systems develops and markets medical devices for the treatment of cardiovascular disease.

Glen D. Nelson: M.D. | Chairman of the BoardPast Role: Medtronic, Executive Vice President
About the Company
Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Their primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications.
Cardiovascular Systems develop solutions for the treatment
of peripheral and coronary artery disease, to help physicians conquer calcium, one of the largest challenges when treating PAD and CAD.